5 Takeaways From the FDA’s Hearing on CBD

5 Takeaways From the FDA’s Hearing on CBD After ten hours of testimony about cannabidiol (CBD) from more than 100 stakeholders, two things are clear: The American public has a high desire for CBD products, and too many CBD manufacturers are delivering shoddy goods. On Friday, FDA Acting Commissioner Ned Sharpless kicked off the... more →
Posted in: News

Vapen MJ Ventures Reports 47.8% Revenue Increase, 55.8% Increase in Net Income, for First Quarter of 2019

Vapen MJ Ventures Reports 47.8% Revenue Increase, 55.8% Increase in Net Income, for First Quarter of 2019 Vapen MJ Ventures Corporation (CSE: VAPN) (“Vapen MJ”) a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, today reported financial results for the first... more →
Posted in: News

Next Green Wave Provides Corporate Update

Next Green Wave Provides Corporate Update Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) The CEO and Executive Chairman of NGW, Leigh Hughes is pleased to provide an update on the progress of The Company’s operations. As a young public company, we continue to demonstrate the energy, drive and passion of a “start-up”... more →
Posted in: News

FDA Holds First Public Hearing on CBD

FDA Holds First Public Hearing on CBD It’s a big day in the world of cannabis. The Food and Drug Administration (FDA) is holding its first public hearing on how it should regulate CBD Friday. This could be a gamechanger—for the best or the worse—for cannabis’ non-psychoactive compound. This hearing will be the first step... more →
Posted in: News

Aurora Cannabis Exercises License Option with EnWave

Aurora Cannabis Exercises License Option with EnWave VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) – EnWave Corporation (TSX-V:ENW | FSE:E4U) reports today that, following its April 26, 2019 joint news release with Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (NYSE: ACB), a global leader in the cannabis industry,... more →
Posted in: News

Curaleaf Q1 marijuana revenue climbs to $35.3 million

Curaleaf Q1 marijuana revenue climbs to $35.3 million Curaleaf, a Massachusetts-based, vertically integrated cannabis company, reported first-quarter revenue of $35.3 million, up from $9.1 million for the same period in 2018. Net loss for the company in the period totaled $10.8 million versus $3.4 million last year. Curaleaf,... more →
Posted in: News
1 2 3 4 5 6 193